jueves, 14 de septiembre de 2017

Prellis Biologics raises $1.8M to develop microvasculature 3D printing tech for human organ printing

Prellis Biologics, a San Francisco-based human tissue engineering company, says it has invented a new way to create viable human organs using 3D printing. The company has also raised $1.8 million in a seed funding round.

from 3ders.org - http://www.3ders.org

John

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.

 

Copyright @2016